Immuneel raises ₹100 crore in Series B funding to expand CAR-T therapy operations and global… EP News Bureau Jun 9, 2026 Immuneel Therapeutics outlines plans to scale manufacturing, advance its cell and gene therapy pipeline, commercialise Qartemi…
Blood cancers dominate CAR-T pipeline: GlobalData EP News Bureau Mar 21, 2025 According to GlobalData’s Drugs Database, blood cancers account for over half of all CAR-Ts in the active pipeline* and make up…
Immuneel Therapeutics launches Qartemi, a CAR T-cell therapy for Non-Hodgkin’s Lymphoma EP News Bureau Jan 20, 2025 Immuneel has collaborated with hospitals including Narayana Health, Apollo Hospitals, CMC Vellore, Manipal Hospitals among others…
